Table 2.
Clinicopathologic summary of patients who underwent hysterectomy
Clinical diagnosis | Case | MRI finding | Cytology | HIK test | Cervical biopsy | Mode of surgery | Pathological diagnosis | LM / LVSI | Ovarian‐meta | Stage | F/U period (months) | Status at last F/U |
---|---|---|---|---|---|---|---|---|---|---|---|---|
S/O MDA‐Ca | 1 | Solid and invasion pattern | Adenoca. | NA | Adenoca. | RH, BSO, PLN | Serous adenoca, LEGH | − | − | IB1 | 68 | Alive |
2 | Solid and invasion pattern | AGC‐FN | + | Adenoca. | RH, BSO, PLN, PAN | GAS, MDA, LEGH with atypia, LEGH | + | − | IIB | 33 | Alive | |
3 | Solid pattern | AGC‐FN | + | Adenoca. | RH, BSO, PLN | GAS, Endocervical type muc. adenoca. | + | + | IIA1 | 19 | DOD | |
4 | Solid pattern | AGC‐FN | NA | MDA | TAH, BSO, PLN, PAN | GAS, MDA | + | + | IB2 | 5 | DOD | |
5 | Solid pattern | Adenoca. | + | Adenoca. | RH, BSO, PLN. PAN | GAS, MDA, LEGH | + | − | IB2 | 3 | Alive | |
6 | Microcystic pattern | AGC‐FN | + | Adenoca. | TAH, BSO | GAS, LEGH | − | − | IIA1 | 4 | Alive | |
7 | Solid pattern | AGC‐NOS | NA | NA | RH, BSO, PLN | MDA | − | − | IB1 | 24 | DOD | |
8 | Microcystic pattern | AGC‐FN | + | NA | TAH | LEGH with atypia | − | − | − | 63 | Alive | |
9 | Solid and invasion pattern | NILM | − | Normal | TAH, BSO | LEGH with atypia + mucinous adenoma | − | − | − | 20 | Alive | |
10 | Microcystic pattern | NILM | NA | Normal | RH, BSO, PLN | LEGH | − | − | − | 131 | Alive | |
S/O LEGH | 11 | Cosmos pattern | NILM | + | NA | TAH | LEGH with atypia | − | − | − | 32 | Alive |
12 | Cosmos pattern | AGC‐NOS | + | NA | TAH | LEGH | − | − | − | 33 | Alive | |
13 | Coarse cystic pattern | AGC‐NOS | + | NA | TAH | LEGH | − | − | − | 85 | Alive | |
14 | Microcystic pattern | AGC‐NOS | + | LEGH | TAH, BSO | LEGH | − | − | − | 33 | DOO | |
15 | Cosmos pattern | AGC‐NOS | + | NA | TAH | LEGH | − | − | − | 21 | Alive | |
16 | Cosmos pattern | NILM | + | Normal | TAH | LEGH | − | − | − | 61 | Alive | |
17 | Cosmos pattern | NILM | + | LEGH | TAH, BSO | LEGH | − | − | − | 12 | Alive | |
18 | Cosmos pattern | AGC‐NOS | + | NA | TLH, BSO | LEGH | − | − | − | 17 | Alive | |
19 | Coarse cystic pattern | NILM | + | NA | TAH | LEGH | − | − | − | 136 | Alive | |
20 | Coarse cystic pattern | NILM | + | Normal | TAH, BSO | LEGH | − | − | − | 122 | Alive |
Adenoca., adenocarcinoma; AGC‐FN: atypical glandular cells‐favor neoplastic, AGC‐NOS: atypical glandular cells‐not otherwise significant, BSO: bilateral salpingo‐oophorectomy, DOD: dead of disease, DOO: dead of other causes; F/U, follow‐up; GAS: gastric‐type adenocarcinoma, LEGH: lobular endocervical glandular hyperplasia, LM: lymph node metastasis, LVSI: lymphovascular space invasion, MDA, minimal deviation adenocarcinoma; MRI, magnetic resonance imaging; muc. adenoca., mucinous adenocarcinoma; NA, not available; NILM, negative for intraepithelial lesion or malignancy; PAN: para‐aortic lymphadenectomy, PLN: pelvic lymphadenectomy, RH: radical hysterectomy, TAH: total abdominal hysterectomy, TLH: total laparoscopic hysterectomy; S/O MDA‐Ca, suspicious of minimal deviation adenocarcinoma or carcinoma; S/O LEGH, suspicious of lobular endocervical glandular hyperplasia.